Trials / Completed
CompletedNCT00743444
TLESR-impedance Study in Patients
A Double-blind, Placebo Controlled, Randomized, Two Centre Phase IIA Pharmacodynamic Cross-over Study to Assess the Effect of AZD3355, 65 mg Bid, on Transient Lower Esophageal Sphincter Relaxations (TLESRs) in GERD Patients With an Incomplete Response to PPI Treatment
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to compare frequency and content of reflux episodes in patients with gastroesophageal reflux disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AZD3355 | 65 mg capsules, oral, 3 single doses |
| DRUG | Placebo | capsules, oral, 3 single doses |
Timeline
- Start date
- 2007-02-01
- Primary completion
- 2008-02-01
- Completion
- 2008-02-01
- First posted
- 2008-08-28
- Last updated
- 2013-07-22
- Results posted
- 2011-06-10
Source: ClinicalTrials.gov record NCT00743444. Inclusion in this directory is not an endorsement.